Emory University has named Santa Ono to the newly created post of vice provost for academic initiatives. Ono, who currently is associate dean of students and GlaxoSmithKline Professor of Biomedical Sciences at University College, London (UCL), will also serve as deputy to Provost Earl Lewis and as professor of ophthalmology at the School of Medicine. He will begin his new post on July 3.
“Santa’s considerable administrative experience in strategic planning and student academic services, as well as his enthusiasm for innovative research and teaching, are ideal for this new role. I am confident he will make great contributions to the university and provide key leadership as we work to achieve Emory’s immediate and long-range goals,” said Lewis.
As vice provost, Ono will work with other senior staff to coordinate
the implementation of the university’s strategic plan and oversee specific projects.
“It is a distinct honor to join Emory,” said Ono. “Emory is a stunning institution, both steeped in tradition and renowned for its pioneering spirit. But it is the university’s future that has attracted me to join the provost’s office. On the landscape of leading global universities, there are very few that will keep pace with what shall be accomplished at Emory in the next ten years.”
Ono received his undergraduate degree in biological sciences at the University of Chicago and his . in experimental medicine from McGill University in Montreal. He finished his postdoctoral training in the department of biochemistry and molecular biology at Harvard.
In 1992, Ono was appointed assistant professor of medicine, pathology and biology at The Johns Hopkins University, where he won both the American Diabetes Association Career Development Award and the Investigator Award from the National Arthritis Foundation. In 1996, Ono was recruited back to Harvard University, where he was an associate professor and director of the Immunity, Inflammation and Transplantation Focus Group at the Schepens Eye Research Institute. He was recruited to the GlaxoSmithKline chair at UCL and Moorfields Eye Hospital in 2001.